Literature DB >> 11240002

Individual differences in rat locomotor activity are diminished by nicotine through stimulation of central nicotinic acetylcholine receptors.

R A Bevins1, J Besheer.   

Abstract

An increasing body of research has focused on isolating factors that predict or alter individual differences in the behavioral and neural processes mediating the effects of abused drugs. Within this framework, the current report assessed individual differences and the locomotor effect of nicotine. Rats were screened for activity induced by a novel environment. Rats, which were more active to initial environment exposure, remained more active even after seven additional 30-min exposures to the same environment. Treatment with nicotine-di-D tartrate (1 mg/kg, sc) disrupted this effect. This nicotine disruption of individual differences occurred whether nicotine suppressed locomotor activity (initial administration) or stimulated locomotor activity (seventh and eighth administration). Mecamylamine (1 mg/kg), but not hexamethonium (10 mg/kg), completely blocked the suppressant and stimulant effects of nicotine. Further, mecamylamine restored the nicotine-induced disruption of individual differences; hexamethonium had no effect. This data pattern suggests that the disruptive effects of acute and chronic nicotine on individual differences were mediated by neural nicotinic acetylcholine (nACh) receptors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11240002     DOI: 10.1016/s0031-9384(00)00413-3

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  12 in total

1.  Age-dependent effects of nicotine on locomotor activity and conditioned place preference in rats.

Authors:  James D Belluzzi; Alex G Lee; Heather S Oliff; Frances M Leslie
Journal:  Psychopharmacology (Berl)       Date:  2004-01-22       Impact factor: 4.530

2.  Restraint stress attenuates nicotine's locomotor stimulant but not discriminative stimulus effects in rats.

Authors:  Andrew C Harris; Christina Mattson; David Shelley; Mark G LeSage
Journal:  Pharmacol Biochem Behav       Date:  2014-05-24       Impact factor: 3.533

3.  Repeated nicotine treatment in rats with high versus low rearing activity: analyses of behavioural sensitisation and place preference.

Authors:  Cornelius R Pawlak; Rainer K W Schwarting
Journal:  Psychopharmacology (Berl)       Date:  2004-11-17       Impact factor: 4.530

4.  Mecamylamine, dihydro-beta-erythroidine, and dextromethorphan block conditioned responding evoked by the conditional stimulus effects of nicotine.

Authors:  Amanda M Struthers; Jamie L Wilkinson; Linda P Dwoskin; Peter A Crooks; Rick A Bevins
Journal:  Pharmacol Biochem Behav       Date:  2009-09-22       Impact factor: 3.533

5.  Individual differences in responses to nicotine: tracking changes from adolescence to adulthood.

Authors:  Ming Li; Alexa Mead; Rick A Bevins
Journal:  Acta Pharmacol Sin       Date:  2009-06       Impact factor: 6.150

6.  Nicotine enhances operant responding for qualitatively distinct reinforcers under maintenance and extinction conditions.

Authors:  Scott T Barret; Rick A Bevins
Journal:  Pharmacol Biochem Behav       Date:  2013-12       Impact factor: 3.533

Review 7.  Individual differences in the behavioral effects of nicotine: A review of the preclinical animal literature.

Authors:  Adriana M Falco; Rick A Bevins
Journal:  Pharmacol Biochem Behav       Date:  2015-09-26       Impact factor: 3.533

8.  A quantitative analysis of the reward-enhancing effects of nicotine using reinforcer demand.

Authors:  Scott T Barrett; Rick A Bevins
Journal:  Behav Pharmacol       Date:  2012-12       Impact factor: 2.293

9.  The effect of previous exposure to nicotine on nicotine place preference.

Authors:  Verónica Pastor; María Estela Andrés; Ramón O Bernabeu
Journal:  Psychopharmacology (Berl)       Date:  2012-11-30       Impact factor: 4.530

10.  Evidence of Altered Brain Responses to Nicotine in an Animal Model of Attention Deficit/Hyperactivity Disorder.

Authors:  Guillaume L Poirier; Wei Huang; Kelly Tam; Joseph R DiFranza; Jean A King
Journal:  Nicotine Tob Res       Date:  2017-09-01       Impact factor: 4.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.